SCHEMBL14382142

SCHEMBL14382142

Cc1ccc(C#N)c(N=[N+]=[N-])c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 10/20 0.36
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ PKM P14618 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ ERBB2 P04626 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ IMPDH2 P12268 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ FFAR1 O14842 1/20 0.31
▸ CYP11B1 P15538 1/20 0.31
▸ CYP11B2 P19099 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ ALOX12 P18054 1/20 0.31
▸ BRCA1 P38398 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14691380 0.79 VCAM1 (0.41) ARALDH1A1CYP2A6KMT2ATSHR
SCHEMBL27098091 0.77 NPC1 (0.38) CYP2A6KMT2APKMKDM4EMAPT
SCHEMBL27527094 0.76 AR (0.37) ARTSHR
SCHEMBL28254037 0.76 AR (0.39) ARALDH1A1CYP2A6KMT2APKM
SCHEMBL14306432 0.75 TUBB4A (0.46) ALDH1A1CYP2A6KMT2APKMKDM4E
SCHEMBL25257701 0.73 CYP11B2 (0.47) ARALDH1A1KMT2AKDM4ECYP11B1
SCHEMBL30510146 0.73 CYP11B2 (0.47) ARALDH1A1KMT2AKDM4ECYP11B1
SCHEMBL28320699 0.73 LMNA (0.42) ALDH1A1KMT2AEGFRERBB2TSHR
SCHEMBL27547023 0.72 AR (0.35) AR
SCHEMBL14394775 0.72 NPC1 (0.35) ALDH1A1CYP2A6KMT2APKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1854798-A2 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Bristol-Myers Squibb Company (US) 2007-11-14 — — EP disclosed
Send feedback